Commentary

As of 31 December 2025

Market Overview

− Global equity markets delivered mostly strong returns in the fourth quarter of 2025, supported by moderating inflation and a shift in central bank tone toward policy normalization.

− The United States S&P 500 index rose 2.4%, the UK FTSE 100 index increased 6.2%, the Japanese Nikkei 225 lifted 12.0%, the Australian ASX 200 index lost -1.0%.

− The S&P/NZX 50 index gained 2.0%.

Fund Highlights

− The fund ended the month down 0.3%, and behind the index return. For the quarter the fund returned 1.1%, 0.9% behind the index return.

− News flow was dominated by earnings results for the period ended September, along with Annual Shareholder Meetings for companies with June year ends.

− The fund’s foreign currency hedge was increased to 75%.

− An overweight position in Summerset and underweights (nil holdings) in Precinct and Goodman Property added value. Overweight positions in NextDC, Infratil and Resmed detracted from value.

Performance

GoalsGetter Amova SRI Equity Fund
Open Close

Performance

at 31 December 2025
One month Three months One year Three years (p.a) Five years (p.a)
Fund performance1 -0.37% 0.82% 1.91% 6.04% 1.65%
Appropriate Market Index (AMI)2 0.50% 2.02% 4.08% 6.54% 1.46%
  1. Returns are before tax and after the deduction of fees and expenses and including tax credits (if any).
  2. AMI: S&P/NZX 50 Index Gross with Imputation Credits.

    The Amova KiwiSaver Scheme SRI Equity Fund transitioned from core strategy to SRI strategy in February 2022.

5 year cumulative performance $10,000 invested

GoalsGetter KiwiSaver Scheme

Top 10 Holdings

Security Name Percentage
Fisher & Paykel Healthcare 14.98%
Infratil Limited 9.60%
Auckland International Airport Ltd 9.40%
Meridian Energy Ltd NPV 6.48%
Contact Energy Limited 6.03%
The A2 Milk Company Limited 5.45%
Spark New Zealand Ltd 4.73%
EBOS Group Limited 4.47%
Mainfreight Limited 3.97%
NZD BNP Paribas A/C 3.94%